Global /China /Healthcare /Biotechnology /688526

Wuhan Keqian Biology Co.,Ltd

688526

• SSE: 688526 • Delayed

14.41CNY -1.8%

2.12 USD

As of 27 June 2026, Wuhan Keqian Biology Co.,Ltd has a market cap of $1.0B USD, ranking #10668 globally and #3008 in China. It ranks #956 in the Healthcare sector, and #182 in the Biotechnology industry.

Global Rank

10668

1d: -

1w: -

1m: -

Country Rank

3008

Sector Rank

956

Industry Rank

182

Key Stats

Market Cap

$1.0BUSD

6.81B CNY

Enterprise Value

$651.86MUSD

4.43B CNY

Revenue (TTM)

$139.85MUSD

949.74M CNY

EBITDA (TTM)

$71.01MUSD

482.99M CNY

Net Income (TTM)

$61.66MUSD

418.72M CNY

EBITDA Margin

51%

Profit Margin

44%

PE Ratio

16.3

Forward PE

14.3

PS Ratio

7.2

PB Ratio

1.6

EV/EBITDA

9.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Mulin Chen open_in_new

Employees

922

Founded

2001

Website

kqbio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.8%	-2.5%	-0.1%	-13%	-14%	-3.8%	-7%	-43%	-64%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688526 武汉科前生物股份有限公司 Class A ISIN: CNE1000042Q8 Shares Out.: Shares Outstanding: 463.916M¹ Shares Float: 463.896M² TV: TradingView: SSE: 688526 SA: Stock Analysis: SHA: 688526 YF: Yahoo Finance: 688526.SS GF: Google Finance: SHA: 688526 BA: Barron's: 688526 MS: Morningstar: XSHG: 688526	14.41 CNY	TV: TradingView: SSE: 688526 SA: Stock Analysis: SHA: 688526 YF: Yahoo Finance: 688526.SS GF: Google Finance: SHA: 688526 BA: Barron's: 688526 MS: Morningstar: XSHG: 688526

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Wuhan Keqian Biology Co.,Ltd

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.44B 136.71B HKD 2K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.19B 95.58B HKD 1K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$7.99B 54.23B CNY 696%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.32B 49.69B CNY 630%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 606%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.7B 45.52B CNY 568%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 18K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 16K%	19.0	United States
argenx SE EBR: ARGX	$47.08B 41.39B EUR 5K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.15B 68.19T KRW 4K%	35.5	South Korea
CSL Ltd. ASX: CSL	$41.67B 60.27B AUD 4K%	29.3	Australia
Lonza Group AG SIX: LONN	$41.63B 33.71B CHF 4K%	37.2	Switzerland

chevron_leftBack